Yahoo
NYSE - Nasdaq Real Time Price USD

Cardinal Health, Inc. (CAH)

253.74 +2.65 (+1.05%)
As of 2:04:11 PM EDT. Market Open.
Trade CAH on Coinbase
Chart Range Bar
Loading chart for CAH

What's happening with CAH?

9m ago
Powered by Yahoo Scout

Cardinal Health enters its November 5, 2026 earnings reportafter strong fiscal 2026 results and sustained analyst interest. The central question is whether earnings growth and higher-margin businesses can justify a valuation that has expanded significantly. Consensus forecasts point to higher revenue and earnings, while analyst ratings and fair-value estimates remain divided.

Powered by Yahoo Scout
  • Previous Close 251.09
  • Open 255.02
  • Bid 253.45 x 10000
  • Ask 253.92 x 20000
  • Day's Range 252.43 - 259.84
  • 52 Week Range 180.45 - 259.84
  • Volume 748,416
  • Avg. Volume 1,779,657
  • Market Cap (intraday) 58.755B
  • Beta (5Y Monthly) 0.50
  • PE Ratio (TTM) 35.09
  • EPS (TTM) 7.23
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield 2.06 (0.82%)
  • 1y Target Est 273.47
  • Morningstar Rating Rating available with Stock Picks access

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

www.cardinalhealth.com

58,788

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CAH
24.64%
S&P 500 (^GSPC)
10.18%

1-Year Return

CAH
34.92%
S&P 500 (^GSPC)
10.55%

3-Year Return

CAH
190.92%
S&P 500 (^GSPC)
81.01%

5-Year Return

CAH
487.52%
S&P 500 (^GSPC)
63.77%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY26
Revenue 63.67B
Earnings 398M
Profit Margin 0.63%

Q1

FY26

Q2

FY26

Q3

FY26

Q4

FY26

0
20B
40B
60B
0.6%
0.7%
0.7%
0.7%

Analyst Insights

View More

Analyst Price Targets

235.00 Low
273.47 Average
253.74 Current
295.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/30/2026
Analyst Morgan Stanley
Rating Action Maintains
Rating Overweight
Price Action Raises
Price Target 265 -> 286

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.67%

  • Return on Assets (ttm)

    3.72%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    254.25B

  • Net Income Avi to Common (ttm)

    1.71B

  • Diluted EPS (ttm)

    7.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.86B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    4.75B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: